These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18158729)

  • 1. The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes.
    Tian Y; Zhang HH; Wei L; Du SC; Chen HS; Fei R; Liu F
    Viral Immunol; 2007 Dec; 20(4):553-61. PubMed ID: 18158729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
    Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
    Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative analysis of the immune response to DNA constructions encoding hepatitis C virus nonstructural proteins].
    Masalova OV; Lesnova EI; Ivanov AV; Pichugin AV; Permiakova KIu; Smirnova OA; Tynitskaia VL; Ulanova TI; Burkov AN; Kochetkov SN; Ataullakhanov RI; Kushch AA
    Vopr Virusol; 2013; 58(2):21-8. PubMed ID: 23785766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine.
    Li W; Krishnadas DK; Kumar R; Tyrrell DL; Agrawal B
    Int Immunol; 2008 Jan; 20(1):89-104. PubMed ID: 18006878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
    Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
    Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
    Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
    Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
    Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
    Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
    Echeverría I; Zabaleta A; Silva L; Díaz-Valdés N; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Civeira MP; Prieto J; Sarobe P
    J Viral Hepat; 2008 Nov; 15(11):782-9. PubMed ID: 18637068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
    Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P
    Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
    Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
    J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.
    Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Viral Hepat; 2008 Jun; 15(6):459-70. PubMed ID: 18221298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.
    Vajdy M; Selby M; Medina-Selby A; Coit D; Hall J; Tandeske L; Chien D; Hu C; Rosa D; Singh M; Kazzaz J; Nguyen S; Coates S; Ng P; Abrignani S; Lin YL; Houghton M; O'Hagan DT
    J Gen Virol; 2006 Aug; 87(Pt 8):2253-2262. PubMed ID: 16847121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.
    Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM
    J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
    Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
    Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Núñez-Roldán A; Aguilar-Reina J
    J Viral Hepat; 2011 Oct; 18(10):e541-9. PubMed ID: 21914075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a dendritic cell vaccine encoding multiple cytotoxic T lymphocyte epitopes targeting hepatitis C virus.
    Zhou Y; Zhao F; Chen L; Ma L; Wang Y; He Y; Ma Z; Liu H; Guo Y; Zhang Y; Yao Z; Hao C; Jia Z
    Int J Mol Med; 2013 Oct; 32(4):901-9. PubMed ID: 23934073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.